| Year |
Citation |
Score |
| 2023 |
Zamecnik CR, Sowa GM, Abdelhak A, Dandekar R, Bair RD, Wade KJ, Bartley CM, Tubati A, Gomez R, Fouassier C, Gerungan C, Alexander J, Wapniarski AE, Loudermilk RP, Eggers EL, ... ... Hauser SL, et al. A Predictive Autoantibody Signature in Multiple Sclerosis. Medrxiv : the Preprint Server For Health Sciences. PMID 37205595 DOI: 10.1101/2023.05.01.23288943 |
0.301 |
|
| 2023 |
Ma Q, Shams H, Didonna A, Baranzini SE, Cree BAC, Hauser SL, Henry RG, Oksenberg JR. Integration of epigenetic and genetic profiles identifies multiple sclerosis disease-critical cell types and genes. Communications Biology. 6: 342. PMID 36997638 DOI: 10.1038/s42003-023-04713-5 |
0.31 |
|
| 2020 |
Didonna A, Canto Puig E, Ma Q, Matsunaga A, Ho B, Caillier SJ, Shams H, Lee N, Hauser SL, Tan Q, Zamvil SS, Oksenberg JR. Ataxin-1 regulates B cell function and the severity of autoimmune experimental encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America. PMID 32878998 DOI: 10.1073/Pnas.2003798117 |
0.332 |
|
| 2020 |
Ramesh A, Schubert RD, Greenfield AL, Dandekar R, Loudermilk R, Sabatino JJ, Koelzer MT, Tran EB, Koshal K, Kim K, Pröbstel AK, Banerji D, Guo CY, Green AJ, ... ... Hauser SL, et al. A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. PMID 32859762 DOI: 10.1073/Pnas.2008523117 |
0.345 |
|
| 2020 |
Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, et al. Ofatumumab versus Teriflunomide in Multiple Sclerosis. The New England Journal of Medicine. 383: 546-557. PMID 32757523 DOI: 10.1056/Nejmoa1917246 |
0.333 |
|
| 2020 |
Caverzasi E, Cordano C, Zhu AH, Zhao C, Bischof A, Kirkish G, Bennett DJ, Devereux M, Baker N, Inman J, Yiu HH, Papinutto N, Gelfand JM, Cree BAC, Hauser SL, et al. Imaging correlates of visual function in multiple sclerosis. Plos One. 15: e0235615. PMID 32745132 DOI: 10.1371/Journal.Pone.0235615 |
0.333 |
|
| 2020 |
Hauser SL, Kappos L, Arnold DL, Bar-Or A, Brochet B, Naismith RT, Traboulsee A, Wolinsky JS, Belachew S, Koendgen H, Levesque V, Manfrini M, Model F, Hubeaux S, Mehta L, et al. Five-years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension. Neurology. PMID 32690791 DOI: 10.1212/Wnl.0000000000010376 |
0.323 |
|
| 2020 |
Hauser SL, Cree BAC. Treatment of Multiple Sclerosis: A Review. The American Journal of Medicine. PMID 32682869 DOI: 10.1016/J.Amjmed.2020.05.049 |
0.419 |
|
| 2020 |
Schleimer E, Pearce J, Barnecut A, Rowles W, Lizee A, Klein A, Block VJ, Santaniello A, Renschen A, Gomez R, Keshavan A, Gelfand JM, Henry RG, Hauser SL, Bove R. A Precision Medicine Tool for Patients With Multiple Sclerosis (the Open MS BioScreen): Human-Centered Design and Development. Journal of Medical Internet Research. 22: e15605. PMID 32628124 DOI: 10.2196/15605 |
0.4 |
|
| 2020 |
Sádaba MC, Rothhammer V, Muñoz Ú, Sebal C, Escudero E, Kivisäkk P, Garcia Sanchez MI, Izquierdo G, Hauser SL, Baranzini SE, Oksenberg JR, Álvarez-Lafuente R, Bakshi R, Weiner HL, Quintana FJ. Serum antibodies to phosphatidylcholine in MS. Neurology(R) Neuroimmunology & Neuroinflammation. 7. PMID 32518205 DOI: 10.1212/Nxi.0000000000000765 |
0.327 |
|
| 2020 |
Kappos L, Wolinsky JS, Giovannoni G, Arnold DL, Wang Q, Bernasconi C, Model F, Koendgen H, Manfrini M, Belachew S, Hauser SL. Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials. Jama Neurology. PMID 32511687 DOI: 10.1001/Jamaneurol.2020.1568 |
0.395 |
|
| 2020 |
Hauser SL. Progress in Multiple Sclerosis Research: An Example of Bedside to Bench. Jama. PMID 32379266 DOI: 10.1001/Jama.2020.1522 |
0.35 |
|
| 2020 |
Bakshi R, Healy BC, Dupuy SL, Kirkish G, Khalid F, Gundel T, Asteggiano C, Yousuf F, Alexander A, Hauser SL, Weiner HL, Henry RG. Brain MRI Predicts Worsening Multiple Sclerosis Disability over 5 Years in the SUMMIT Study. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 31994814 DOI: 10.1111/Jon.12688 |
0.375 |
|
| 2020 |
Gouider R, Giovannoni G, Kappos L, Hauser SL, Montalban X, Koendgen H, Prajapati K, Manfrini M, Wolinsky JS. Long-Term Reduction of Relapse Rate and Confirmed Disability Progression After 6 Years of Ocrelizumab Treatment in Patients with Relapsing Multiple Sclerosis Multiple Sclerosis and Related Disorders. 37: 101593. DOI: 10.1016/J.Msard.2019.11.068 |
0.323 |
|
| 2019 |
Azevedo CJ, Cen SY, Jaberzadeh A, Zheng L, Hauser SL, Pelletier D. Contribution of normal aging to brain atrophy in MS. Neurology(R) Neuroimmunology & Neuroinflammation. 6. PMID 32330116 DOI: 10.1212/Nxi.0000000000000616 |
0.339 |
|
| 2019 |
Sabatino JJ, Wilson MR, Calabresi PA, Hauser SL, Schneck JP, Zamvil SS. Anti-CD20 therapy depletes activated myelin-specific CD8 T cells in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. PMID 31748274 DOI: 10.1073/Pnas.1915309116 |
0.352 |
|
| 2019 |
Krysko KM, Henry RG, Cree BAC, Lin J, Caillier S, Santaniello A, Zhao C, Gomez R, Bevan C, Smith DL, Stern W, Kirkish G, Hauser SL, Oksenberg JR, et al. Telomere length is associated with disability progression in multiple sclerosis. Annals of Neurology. PMID 31486104 DOI: 10.1002/Ana.25592 |
0.392 |
|
| 2019 |
Barkhof F, Kappos L, Wolinsky JS, Li DKB, Bar-Or A, Hartung HP, Belachew S, Han J, Julian L, Sauter A, Napieralski J, Koendgen H, Hauser SL. Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis. Neurology. PMID 31484710 DOI: 10.1212/Wnl.0000000000008189 |
0.361 |
|
| 2019 |
Midaglia L, Mulero P, Montalban X, Graves J, Hauser SL, Julian L, Baker M, Schadrack J, Gossens C, Scotland A, Lipsmeier F, van Beek J, Bernasconi C, Belachew S, Lindemann M. Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study. Journal of Medical Internet Research. 21: e14863. PMID 31471961 DOI: 10.2196/14863 |
0.316 |
|
| 2019 |
Cantó E, Barro C, Zhao C, Caillier SJ, Michalak Z, Bove R, Tomic D, Santaniello A, Häring DA, Hollenbach J, Henry RG, Cree BAC, Kappos L, Leppert D, Hauser SL, et al. Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years. Jama Neurology. PMID 31403661 DOI: 10.1001/Jamaneurol.2019.2137 |
0.38 |
|
| 2019 |
Cree BAC, Hauser SL. Reply to "Silent progression or bout-onset progressive multiple sclerosis?" Annals of Neurology. PMID 31251816 DOI: 10.1002/Ana.25536 |
0.39 |
|
| 2019 |
Didonna A, Cantó E, Shams H, Isobe N, Zhao C, Caillier SJ, Condello C, Yamate-Morgan H, Tiwari-Woodruff SK, Mofrad MRK, Hauser SL, Oksenberg JR. Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation. Journal of Autoimmunity. PMID 31010726 DOI: 10.1016/J.Jaut.2019.04.003 |
0.326 |
|
| 2019 |
Cree BAC, Hollenbach JA, Bove R, Kirkish G, Sacco S, Caverzasi E, Bischof A, Gundel T, Zhu AH, Papinutto N, Stern WA, Bevan C, Romeo A, Goodin DS, ... ... Hauser SL, et al. Silent Progression in Disease Activity-Free Relapsing Multiple Sclerosis. Annals of Neurology. PMID 30851128 DOI: 10.1002/Ana.25463 |
0.396 |
|
| 2019 |
Mayer L, Kappos L, Racke MK, Rammohan K, Traboulsee A, Hauser SL, Julian L, Köndgen H, Li C, Napieralski J, Zheng H, Wolinsky JS. Ocrelizumab infusion experience in patients with relapsing and primary progressive multiple sclerosis: Results from the phase 3 randomized OPERA I, OPERA II, and ORATORIO studies. Multiple Sclerosis and Related Disorders. 30: 236-243. PMID 30844611 DOI: 10.1016/J.Msard.2019.01.044 |
0.376 |
|
| 2019 |
Turner B, Cree BAC, Kappos L, Montalban X, Papeix C, Wolinsky JS, Buffels R, Fiore D, Garren H, Han J, Hauser SL. Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis. Journal of Neurology. PMID 30820738 DOI: 10.1007/S00415-019-09248-6 |
0.304 |
|
| 2019 |
Greenfield AL, Dandekar R, Ramesh A, Eggers EL, Wu H, Laurent S, Harkin W, Pierson NS, Weber MS, Henry RG, Bischof A, Cree BA, Hauser SL, Wilson MR, von Büdingen HC. Longitudinally persistent cerebrospinal fluid B-cells can resist treatment in multiple sclerosis. Jci Insight. PMID 30747723 DOI: 10.1172/Jci.Insight.126599 |
0.346 |
|
| 2019 |
Cordano C, Nourbakhsh B, Devereux M, Damotte V, Bennett D, Hauser SL, Cree BAC, Gelfand JM, Green AJ. pRNFL as a marker of disability worsening in the medium/long term in patients with MS. Neurology(R) Neuroimmunology & Neuroinflammation. 6: e533. PMID 30697584 DOI: 10.1212/Nxi.0000000000000533 |
0.377 |
|
| 2019 |
Young C, Hauser S, Kappos L, Montalban X, Hughes R, Koendgen H, McNamara J, Pradhan A, Wormser D, Wolinsky J. 177 Updated safety analysis of ocrelizumab in multiple sclerosis Journal of Neurology, Neurosurgery, and Psychiatry. 90. DOI: 10.1136/Jnnp-2019-Abn-2.157 |
0.357 |
|
| 2019 |
Hauser S, Kappos L, Montalban X, Craveiro L, Hughes R, McNamara J, Pradhan A, Wormser D, Koendgen H, Wolinsky JS. Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis Journal of the Neurological Sciences. 405: 52. DOI: 10.1016/J.Jns.2019.10.313 |
0.39 |
|
| 2019 |
Giovannoni G, Kappos L, Hauser SL, Montalban X, Koendgen H, Prajapati K, Manfrini M, Mehta L, Wolinsky J. Long-term reduction of relapse rate and confirmed disability progression after 6 years of ocrelizumab treatment in patients with relapsing multiple sclerosis Journal of the Neurological Sciences. 405: 308-309. DOI: 10.1016/J.Jns.2019.10.1401 |
0.323 |
|
| 2019 |
Wolinsky JS, Hartung HP, Brochet B, Montalban X, Naismith RT, Manfrini M, Garas M, Model F, Hubeaux S, Kappos L, Hauser SL. P61 Sustained reduction in confirmed disability progression in patients with primary progressive multiple sclerosis treated with ocrelizumab in the open-label extension period of the Phase III ORATORIO trial Clinical Neurophysiology. 130. DOI: 10.1016/J.Clinph.2019.04.704 |
0.326 |
|
| 2019 |
Hauser SL, Hartung HP, Brochet B, Montalban X, Naismith RT, Wolinsky JS, Manfrini M, Garas M, Model F, Hubeaux S, Kappos L. P60 Long-term reduction of relapse rate and confirmed disability progression after 5 years of ocrelizumab treatment in patients with relapsing multiple sclerosis Clinical Neurophysiology. 130. DOI: 10.1016/J.Clinph.2019.04.703 |
0.321 |
|
| 2019 |
Hauser S, Hartung HP, Kappos L, Montalban X, Hughes R, Koendgen H, McNamara J, Pradhan A, Wormser D, Wolinsky JS. FV 47 Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis Clinical Neurophysiology. 130. DOI: 10.1016/J.Clinph.2019.04.652 |
0.39 |
|
| 2018 |
Elliott C, Wolinsky JS, Hauser SL, Kappos L, Barkhof F, Bernasconi C, Wei W, Belachew S, Arnold DL. Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518814117. PMID 30566027 DOI: 10.1177/1352458518814117 |
0.334 |
|
| 2018 |
Mowry EM, Azevedo CJ, McCulloch CE, Okuda DT, Lincoln RR, Waubant E, Hauser SL, Pelletier D. Body mass index, but not vitamin D status, is associated with brain volume change in MS. Neurology. PMID 30429274 DOI: 10.1212/Wnl.0000000000006644 |
0.301 |
|
| 2018 |
Regev K, Healy BC, Paul A, Diaz-Cruz C, Mazzola MA, Raheja R, Glanz BI, Kivisäkk P, Chitnis T, Jagodic M, Piehl F, Olsson T, Khademi M, Hauser S, Oksenberg J, et al. Identification of MS-specific serum miRNAs in an international multicenter study. Neurology(R) Neuroimmunology & Neuroinflammation. 5: e491. PMID 30175165 DOI: 10.1212/Nxi.0000000000000491 |
0.319 |
|
| 2018 |
Wolinsky JS, Montalban X, Hauser SL, Giovannoni G, Vermersch P, Bernasconi C, Deol-Bhullar G, Garren H, Chin P, Belachew S, Kappos L. Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial. Annals of Neurology. PMID 30155979 DOI: 10.1002/Ana.25313 |
0.348 |
|
| 2018 |
Bove R, Bevan C, Crabtree E, Zhao C, Gomez R, Garcha P, Morrissey J, Dierkhising J, Green AJ, Hauser SL, Cree BA, Wallin MT, Gelfand JM. Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518793527. PMID 30141729 DOI: 10.1177/1352458518793527 |
0.372 |
|
| 2018 |
Jia X, Madireddy L, Caillier S, Santaniello A, Esposito F, Comi G, Stuve O, Zhou Y, Taylor B, Kilpatrick T, Martinelli-Boneschi F, Cree BAC, Oksenberg JR, Hauser SL, Baranzini SE. Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis. Annals of Neurology. PMID 29908077 DOI: 10.1002/Ana.25263 |
0.406 |
|
| 2018 |
Das G, Damotte V, Gelfand JM, Bevan C, Cree BAC, Do L, Green AJ, Hauser SL, Bove R. Rituximab before and during pregnancy: A systematic review, and a case series in MS and NMOSD. Neurology(R) Neuroimmunology & Neuroinflammation. 5: e453. PMID 29564373 DOI: 10.1212/Nxi.0000000000000453 |
0.319 |
|
| 2018 |
Pröbstel AK, Hauser SL. Multiple Sclerosis: B Cells Take Center Stage. Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. PMID 29561328 DOI: 10.1097/Wno.0000000000000642 |
0.312 |
|
| 2018 |
Canto E, Isobe N, Didonna A, Hauser SL, Oksenberg JR. Aberrant STAT phosphorylation signaling in peripheral blood mononuclear cells from multiple sclerosis patients. Journal of Neuroinflammation. 15: 72. PMID 29514694 DOI: 10.1186/S12974-018-1105-9 |
0.351 |
|
| 2018 |
Sabatino JJ, Zamvil SS, Hauser SL. B-Cell Therapies in Multiple Sclerosis. Cold Spring Harbor Perspectives in Medicine. PMID 29358322 DOI: 10.1101/Cshperspect.A032037 |
0.398 |
|
| 2018 |
Azevedo CJ, Cen SY, Khadka S, Liu S, Kornak J, Shi Y, Zheng L, Hauser SL, Pelletier D. Thalamic Atrophy in MS: An MRI Marker of Neurodegeneration Throughout Disease. Annals of Neurology. PMID 29328531 DOI: 10.1002/Ana.25150 |
0.375 |
|
| 2018 |
Damotte V, Lizée A, Tremblay M, Agrawal A, Khankhanian P, Santaniello A, Gomez R, Lincoln R, Tang W, Chen T, Lee N, Villoslada P, Hollenbach JA, Bevan CD, Graves J, ... ... Hauser SL, et al. Harnessing electronic medical records to advance research on multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517747407. PMID 29310490 DOI: 10.1177/1352458517747407 |
0.35 |
|
| 2018 |
Kappos L, Wolinsky JS, Giovannoni G, Arnold DL, Lublin F, Wang Q, Model F, Wei W, Garren H, Manfrini M, Belachew S, Hauser S. 061 Ocrelizumab reduces disability progression independent of relapse activity in patients with relapsing multiple sclerosis (RMS) (ENCORE) Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Anzan.60 |
0.342 |
|
| 2018 |
Hauser S, Brochet B, Montalban X, Naismith R, Wolinsky J, Manfrini M, Garas M, Villoslada P, Model F, Hubeaux S, Kappos L. Long-term Reduction of Relapse Rate and Confirmed Disability progression after 5 years of Ocrelizumab Treatment in Patients with Relapsing Multiple Sclerosis Multiple Sclerosis and Related Disorders. 26: 265-266. DOI: 10.1016/J.Msard.2018.10.105 |
0.323 |
|
| 2018 |
Arnold DL, Kappos L, Hauser SL, Montalban X, Traboulsee A, Wolinsky JS, Manfrini M, Levesque V, Villoslada P, Belachew S, Model F, Hubeaux S, Bar-Or A. Long-term Reduction in Brain MRI Disease Activity and Atrophy after 5 years of Ocrelizumab Treatment in Patients with Relapsing Multiple Sclerosis Multiple Sclerosis and Related Disorders. 26: 265. DOI: 10.1016/J.Msard.2018.10.104 |
0.321 |
|
| 2018 |
Hauser S, Wolinsky J, Brochet B, Montalban X, Naismith R, Manfrini M, Garas M, Villoslada P, Model F, Hubeaux S, Kappos L. Sustained Reduction in Confirmed Disability Progression in Patients with Primary Progressive Multiple Sclerosis Treated with Ocrelizumab in the Open-label Extension Period of the Phase III ORATORIO trial Multiple Sclerosis and Related Disorders. 26: 264-265. DOI: 10.1016/J.Msard.2018.10.103 |
0.328 |
|
| 2018 |
Alroughani R, Hauser SL, Kappos L, Montalban X, Craveiro L, Hughes R, Mcnamara J, Pradhan A, Wormser D, Koendgen H. Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary progressive Multiple Sclerosis Multiple Sclerosis and Related Disorders. 26: 101589. DOI: 10.1016/J.Msard.2018.10.102 |
0.39 |
|
| 2017 |
Bove RM, Hauser SL. Diagnosing multiple sclerosis: art and science. The Lancet. Neurology. PMID 29275980 DOI: 10.1016/S1474-4422(17)30461-1 |
0.348 |
|
| 2017 |
Graves JS, Henry RG, Cree BAC, Lambert-Messerlian G, Greenblatt RM, Waubant E, Cedars MI, Zhu A, Bacchetti P, Hauser SL, Oksenberg JR. Ovarian aging is associated with gray matter volume and disability in women with MS. Neurology. PMID 29273686 DOI: 10.1212/Wnl.0000000000004843 |
0.348 |
|
| 2017 |
Greenfield AL, Hauser SL. B Cell Therapy for Multiple Sclerosis: Entering an Era. Annals of Neurology. PMID 29244240 DOI: 10.1002/Ana.25119 |
0.404 |
|
| 2017 |
Bischof A, Caverzasi E, Cordano C, Hauser SL, Henry RG. Advances in Imaging Multiple Sclerosis. Seminars in Neurology. 37: 538-545. PMID 29207413 DOI: 10.1055/S-0037-1607278 |
0.359 |
|
| 2017 |
Eggers EL, Michel BA, Wu H, Wang SZ, Bevan CJ, Abounasr A, Pierson NS, Bischof A, Kazer M, Leitner E, Greenfield AL, Demuth S, Wilson MR, Henry RG, Cree BA, ... Hauser SL, et al. Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients. Jci Insight. 2. PMID 29202449 DOI: 10.1172/Jci.Insight.92724 |
0.376 |
|
| 2017 |
Green AJ, Gelfand JM, Cree BA, Bevan C, Boscardin WJ, Mei F, Inman J, Arnow S, Devereux M, Abounasr A, Nobuta H, Zhu A, Friessen M, Gerona R, von Büdingen HC, ... ... Hauser SL, et al. Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. Lancet (London, England). PMID 29029896 DOI: 10.1016/S0140-6736(17)32346-2 |
0.368 |
|
| 2017 |
Cekanaviciute E, Yoo BB, Runia TF, Debelius JW, Singh S, Nelson CA, Kanner R, Bencosme Y, Lee YK, Hauser SL, Crabtree-Hartman E, Katz Sand I, Gacias M, Zhu Y, Casaccia P, et al. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proceedings of the National Academy of Sciences of the United States of America. PMID 28893978 DOI: 10.1073/Pnas.1711235114 |
0.388 |
|
| 2017 |
Bove R, Chitnis T, Cree BA, Tintoré M, Naegelin Y, Uitdehaag BM, Kappos L, Khoury SJ, Montalban X, Hauser SL, Weiner HL. SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohorts. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517726657. PMID 28847219 DOI: 10.1177/1352458517726657 |
0.415 |
|
| 2017 |
Gelfand JM, Cree BAC, Hauser SL. Ocrelizumab and Other CD20(+) B-Cell-Depleting Therapies in Multiple Sclerosis. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 28695471 DOI: 10.1007/S13311-017-0557-4 |
0.381 |
|
| 2017 |
von Büdingen HC, Bischof A, Eggers EL, Wang S, Bevan CJ, Cree BA, Henry RG, Hauser SL. Onset of secondary progressive MS after long-term rituximab therapy - a case report. Annals of Clinical and Translational Neurology. 4: 46-52. PMID 28078314 DOI: 10.1002/Acn3.377 |
0.38 |
|
| 2017 |
Giovannoni G, Arnold DL, Bar-Or A, Havrdová E, Kappos L, Lublin F, Traboulsee A, Belachew S, Han J, Hauser SL. PO129 Neda analysis by epoch in the opera studies of ocrelizumab Journal of Neurology, Neurosurgery, and Psychiatry. 88. DOI: 10.1136/Jnnp-2017-Abn.159 |
0.306 |
|
| 2017 |
Ziemssen T, Arnold DL, Bar-Or A, Comi G, Hartung HP, Hauser SL, Kappos L, Lublin F, Selmaj K, Traboulsee A, Masterman D, Chin P, Garren H, Wolinsky JS. P 1 Effect of ocrelizumab on magnetic resonance imaging markers of neurodegeneration in patients with relapsing multiple sclerosis – analysis of the phase III, double-blind, double-dummy, interferon beta-1a- controlled OPERA I and OPERA II studies Clinical Neurophysiology. 128. DOI: 10.1016/J.Clinph.2017.06.080 |
0.307 |
|
| 2016 |
Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Rammohan KW, Selmaj K, Traboulsee A, Sauter A, et al. Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis. The New England Journal of Medicine. PMID 28002688 DOI: 10.1056/Nejmoa1606468 |
0.34 |
|
| 2016 |
Antel J, Ban M, Baranzini S, Barcellos L, Barizzone N, Beecham A, Berge T, Bernardinelli L, Booth D, Bos S, Buck D, Butkiewicz M, Celius EG, Comabella M, Compston A, ... ... Hauser S, et al. NR1H3 p.Arg415Gln Is Not Associated to Multiple Sclerosis Risk Neuron. 92: 333-335. PMID 27764667 DOI: 10.1016/J.Neuron.2016.09.052 |
0.316 |
|
| 2016 |
George MF, Briggs FB, Shao X, Gianfrancesco MA, Kockum I, Harbo HF, Celius EG, Bos SD, Hedström A, Shen L, Bernstein A, Alfredsson L, Hillert J, Olsson T, Patsopoulos NA, ... ... Hauser SL, et al. Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies. Neurology. Genetics. 2: e87. PMID 27540591 DOI: 10.1212/Nxg.0000000000000087 |
0.404 |
|
| 2016 |
Cree B, Gourraud PA, Oksenberg JR, Bevan C, Crabtree-Hartman E, Gelfand JM, Goodin DS, Graves J, Green AJ, Mowry E, Okuda DT, Pelletier D, von Büdingen HC, Zamvil SS, Agrawal A, ... ... Hauser SL, et al. Long-term evolution of multiple sclerosis disability in the treatment era. Annals of Neurology. PMID 27464262 DOI: 10.1002/Ana.24747 |
0.341 |
|
| 2016 |
Isobe N, Keshavan A, Gourraud PA, Zhu AH, Datta E, Schlaeger R, Caillier SJ, Santaniello A, Lizée A, Himmelstein DS, Baranzini SE, Hollenbach J, Cree BA, Hauser SL, Oksenberg JR, et al. Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple Sclerosis. Jama Neurology. 73: 795-802. PMID 27244296 DOI: 10.1001/Jamaneurol.2016.0980 |
0.404 |
|
| 2016 |
Khankhanian P, Cozen W, Himmelstein DS, Madireddy L, Din L, van den Berg A, Matsushita T, Glaser SL, Moré JM, Smedby KE, Baranzini SE, Mack TM, Lizée A, de Sanjosé S, Gourraud PA, ... ... Hauser SL, et al. Meta-analysis of genome-wide association studies reveals genetic overlap between Hodgkin lymphoma and multiple sclerosis. International Journal of Epidemiology. PMID 26971321 DOI: 10.1093/Ije/Dyv364 |
0.43 |
|
| 2016 |
Silber E, Arnold D, Bar-Or A, Comi G, Hartung H, Hauser S, Lublin F, Selmaj K, Traboulsee A, Kappos L, investigators Ic. OCRELIZUMAB VS INTERFERON β-1A IN RELAPSING MS: TWO STUDIES Journal of Neurology, Neurosurgery, and Psychiatry. 87. DOI: 10.1136/Jnnp-2016-315106.144 |
0.328 |
|
| 2015 |
Didonna A, Isobe N, Caillier SJ, Li KH, Burlingame AL, Hauser SL, Baranzini SE, Patsopoulos NA, Oksenberg JR. A non-synonymous single-nucleotide polymorphism associated with multiple sclerosis risk affects the EVI5 interactome. Human Molecular Genetics. PMID 26433934 DOI: 10.1093/Hmg/Ddv412 |
0.374 |
|
| 2015 |
Khankhanian P, Matsushita T, Madireddy L, Lizée A, Din L, Moré JM, Gourraud PA, Hauser SL, Baranzini SE, Oksenberg JR. Genetic contribution to multiple sclerosis risk among Ashkenazi Jews. Bmc Medical Genetics. 16: 55. PMID 26212423 DOI: 10.1186/S12881-015-0201-2 |
0.392 |
|
| 2015 |
Tranah GJ, Santaniello A, Caillier SJ, D'Alfonso S, Martinelli Boneschi F, Hauser SL, Oksenberg JR. Mitochondrial DNA sequence variation in multiple sclerosis. Neurology. 85: 325-30. PMID 26136518 DOI: 10.1212/Wnl.0000000000001744 |
0.376 |
|
| 2015 |
Schlaeger R, Papinutto N, Zhu AH, Lobach IV, Bevan CJ, Bucci M, Castellano A, Gelfand JM, Graves JS, Green AJ, Jordan KM, Keshavan A, Panara V, Stern WA, von Büdingen HC, ... ... Hauser SL, et al. Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis. Jama Neurology. PMID 26053119 DOI: 10.1001/Jamaneurol.2015.0993 |
0.313 |
|
| 2015 |
Isobe N, Madireddy L, Khankhanian P, Matsushita T, Caillier SJ, Moré JM, Gourraud PA, McCauley JL, Beecham AH, Piccio L, Herbert J, Khan O, Cohen J, Stone L, ... ... Hauser SL, et al. An ImmunoChip study of multiple sclerosis risk in African Americans. Brain : a Journal of Neurology. 138: 1518-30. PMID 25818868 DOI: 10.1093/Brain/Awv078 |
0.36 |
|
| 2015 |
Matsushita T, Madireddy L, Sprenger T, Khankhanian P, Magon S, Naegelin Y, Caverzasi E, Lindberg RL, Kappos L, Hauser SL, Oksenberg JR, Henry R, Pelletier D, Baranzini SE. Genetic associations with brain cortical thickness in multiple sclerosis. Genes, Brain, and Behavior. 14: 217-27. PMID 25684059 DOI: 10.1111/Gbb.12190 |
0.412 |
|
| 2015 |
Hauser SL. Hematopoietic stem cell transplantation for MS: extraordinary evidence still needed. Jama. 313: 251-2. PMID 25602994 DOI: 10.1001/Jama.2014.18150 |
0.426 |
|
| 2015 |
Goyette P, Boucher G, Mallon D, Ellinghaus E, Jostins L, Huang H, Ripke S, Gusareva ES, Annese V, Hauser SL, Oksenberg JR, Thomsen I, Leslie S, et al. High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nature Genetics. 47: 172-9. PMID 25559196 DOI: 10.1038/Ng.3176 |
0.315 |
|
| 2015 |
Hauser SL. The Charcot Lecture | beating MS: a story of B cells, with twists and turns. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 8-21. PMID 25480864 DOI: 10.1177/1352458514561911 |
0.401 |
|
| 2014 |
Gourraud PA, Henry RG, Cree BA, Crane JC, Lizee A, Olson MP, Santaniello AV, Datta E, Zhu AH, Bevan CJ, Gelfand JM, Graves JS, Goodin DS, Green AJ, von Büdingen HC, ... ... Hauser SL, et al. Precision medicine in chronic disease management: The multiple sclerosis BioScreen. Annals of Neurology. 76: 633-42. PMID 25263997 DOI: 10.1002/Ana.24282 |
0.341 |
|
| 2014 |
Palanichamy A, Apeltsin L, Kuo TC, Sirota M, Wang S, Pitts SJ, Sundar PD, Telman D, Zhao LZ, Derstine M, Abounasr A, Hauser SL, von Büdingen HC. Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis. Science Translational Medicine. 6: 248ra106. PMID 25100740 DOI: 10.1126/Scitranslmed.3008930 |
0.346 |
|
| 2014 |
Schlaeger R, Papinutto N, Panara V, Bevan C, Lobach IV, Bucci M, Caverzasi E, Gelfand JM, Green AJ, Jordan KM, Stern WA, von Büdingen HC, Waubant E, Zhu AH, Goodin DS, ... ... Hauser SL, et al. Spinal cord gray matter atrophy correlates with multiple sclerosis disability. Annals of Neurology. 76: 568-80. PMID 25087920 DOI: 10.1002/Ana.24241 |
0.355 |
|
| 2014 |
Azevedo CJ, Kornak J, Chu P, Sampat M, Okuda DT, Cree BA, Nelson SJ, Hauser SL, Pelletier D. In vivo evidence of glutamate toxicity in multiple sclerosis. Annals of Neurology. 76: 269-78. PMID 25043416 DOI: 10.1002/Ana.24202 |
0.378 |
|
| 2014 |
Palanichamy A, Jahn S, Nickles D, Derstine M, Abounasr A, Hauser SL, Baranzini SE, Leppert D, von Büdingen HC. Rituximab efficiently depletes increased CD20-expressing T cells in multiple sclerosis patients. Journal of Immunology (Baltimore, Md. : 1950). 193: 580-6. PMID 24928997 DOI: 10.4049/Jimmunol.1400118 |
0.321 |
|
| 2014 |
Llufriu S, Kornak J, Ratiney H, Oh J, Brenneman D, Cree BA, Sampat M, Hauser SL, Nelson SJ, Pelletier D. Magnetic resonance spectroscopy markers of disease progression in multiple sclerosis. Jama Neurology. 71: 840-7. PMID 24839987 DOI: 10.1001/Jamaneurol.2014.895 |
0.388 |
|
| 2014 |
Bankoti J, Apeltsin L, Hauser SL, Allen S, Albertolle ME, Witkowska HE, von Büdingen HC. In multiple sclerosis, oligoclonal bands connect to peripheral B-cell responses. Annals of Neurology. 75: 266-76. PMID 24375699 DOI: 10.1002/Ana.24088 |
0.363 |
|
| 2014 |
Harbo HF, Isobe N, Berg-Hansen P, Bos SD, Caillier SJ, Gustavsen MW, Mero IL, Celius EG, Hauser SL, Oksenberg JR, Gourraud PA. Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 660-8. PMID 24099750 DOI: 10.1177/1352458513506503 |
0.427 |
|
| 2013 |
Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, Cotsapas C, Shah TS, Spencer C, Booth D, Goris A, Oturai A, Saarela J, Fontaine B, Hemmer B, ... ... Hauser SL, et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nature Genetics. 45: 1353-60. PMID 24076602 DOI: 10.1038/Ng.2770 |
0.371 |
|
| 2013 |
Hauser SL, Chan JR, Oksenberg JR. Multiple sclerosis: Prospects and promise. Annals of Neurology. 74: 317-27. PMID 23955638 DOI: 10.1002/Ana.24009 |
0.435 |
|
| 2013 |
Isobe N, Damotte V, Lo Re V, Ban M, Pappas D, Guillot-Noel L, Rebeix I, Compston A, Mack T, Cozen W, Fontaine B, Hauser SL, Oksenberg JR, Sawcer S, Gourraud PA. Genetic burden in multiple sclerosis families. Genes and Immunity. 14: 434-40. PMID 23903824 DOI: 10.1038/Gene.2013.37 |
0.43 |
|
| 2013 |
Schulze-Topphoff U, Casazza S, Varrin-Doyer M, Pekarek K, Sobel RA, Hauser SL, Oksenberg JR, Zamvil SS, Baranzini SE. Tob1 plays a critical role in the activation of encephalitogenic T cells in CNS autoimmunity. The Journal of Experimental Medicine. 210: 1301-9. PMID 23797093 DOI: 10.1084/Jem.20121611 |
0.352 |
|
| 2013 |
Isobe N, Gourraud PA, Harbo HF, Caillier SJ, Santaniello A, Khankhanian P, Maiers M, Spellman S, Cereb N, Yang S, Pando MJ, Piccio L, Cross AH, De Jager PL, Cree BA, ... Hauser SL, et al. Genetic risk variants in African Americans with multiple sclerosis. Neurology. 81: 219-27. PMID 23771490 DOI: 10.1212/Wnl.0B013E31829Bfe2F |
0.377 |
|
| 2013 |
Nickles D, Chen HP, Li MM, Khankhanian P, Madireddy L, Caillier SJ, Santaniello A, Cree BA, Pelletier D, Hauser SL, Oksenberg JR, Baranzini SE. Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls. Human Molecular Genetics. 22: 4194-205. PMID 23748426 DOI: 10.1093/Hmg/Ddt267 |
0.423 |
|
| 2013 |
Hauser SL, Josephson SA, Johnston SC. Multiple sclerosis: monotherapy rules. Annals of Neurology. 73: A5-6. PMID 23596013 DOI: 10.1002/Ana.23886 |
0.388 |
|
| 2013 |
Ban M, Caillier S, Mero IL, Myhr KM, Celius EG, Aarseth J, Torkildsen Ø, Harbo HF, Oksenberg J, Hauser SL, Sawcer S, Compston A. No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis. Annals of Neurology. 73: 430-2. PMID 23444327 DOI: 10.1002/Ana.23833 |
0.347 |
|
| 2013 |
Gourraud PA, Sdika M, Khankhanian P, Henry RG, Beheshtian A, Matthews PM, Hauser SL, Oksenberg JR, Pelletier D, Baranzini SE. A genome-wide association study of brain lesion distribution in multiple sclerosis. Brain : a Journal of Neurology. 136: 1012-24. PMID 23412934 DOI: 10.1093/Brain/Aws363 |
0.349 |
|
| 2013 |
McElroy JP, Krupp LB, Johnson BA, McCauley JL, Qi Z, Caillier SJ, Gourraud PA, Yu J, Nathanson L, Belman AL, Hauser SL, Waubant E, Hedges DJ, Oksenberg JR. Copy number variation in pediatric multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1014-21. PMID 23239789 DOI: 10.1177/1352458512469696 |
0.413 |
|
| 2012 |
von Büdingen HC, Kuo TC, Sirota M, van Belle CJ, Apeltsin L, Glanville J, Cree BA, Gourraud PA, Schwartzburg A, Huerta G, Telman D, Sundar PD, Casey T, Cox DR, Hauser SL. B cell exchange across the blood-brain barrier in multiple sclerosis. The Journal of Clinical Investigation. 122: 4533-43. PMID 23160197 DOI: 10.1172/Jci63842 |
0.385 |
|
| 2012 |
Mowry EM, Waubant E, McCulloch CE, Okuda DT, Evangelista AA, Lincoln RR, Gourraud PA, Brenneman D, Owen MC, Qualley P, Bucci M, Hauser SL, Pelletier D. Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis. Annals of Neurology. 72: 234-40. PMID 22926855 DOI: 10.1002/Ana.23591 |
0.316 |
|
| 2012 |
Gourraud PA, Harbo HF, Hauser SL, Baranzini SE. The genetics of multiple sclerosis: an up-to-date review. Immunological Reviews. 248: 87-103. PMID 22725956 DOI: 10.1111/J.1600-065X.2012.01134.X |
0.444 |
|
| 2012 |
Villoslada P, Cuneo A, Gelfand J, Hauser SL, Green A. Color vision is strongly associated with retinal thinning in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 991-9. PMID 22291035 DOI: 10.1177/1352458511431972 |
0.336 |
|
| 2012 |
Hauser S, Kappos L, Li D, Calabresi P, O'Connor P, Bar-Or A, Barkhof F, Wells C, Leppert D, Glanzman R, Tinbergen J. Long-Term Efficacy and Safety of Ocrelizumab in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): Week 96 Results of a Phase II, Randomized, Multicenter Trial (S30.006) Neurology. 78: S30.006-S30.006. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S30.006 |
0.321 |
|
| 2012 |
Kappos L, Leppert D, Timmermann J, Glanzman R, Hauser S. Ocrelizumab in multiple sclerosis: risks and benefits – Author's reply The Lancet. 379: 1197. DOI: 10.1016/S0140-6736(12)60509-1 |
0.314 |
|
| 2011 |
Oksenberg JR, Hauser SL. Decoding multiple sclerosis. Annals of Neurology. 70: A5-7. PMID 22190375 DOI: 10.1002/Ana.22680 |
0.387 |
|
| 2011 |
Patsopoulos NA, Esposito F, Reischl J, Lehr S, Bauer D, Heubach J, Sandbrink R, Pohl C, Edan G, Kappos L, ... ... Hauser SL, et al. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Annals of Neurology. 70: 897-912. PMID 22190364 DOI: 10.1002/Ana.22609 |
0.386 |
|
| 2011 |
Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE, Edkins S, Gray E, Booth DR, ... ... Hauser SL, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 476: 214-9. PMID 21833088 DOI: 10.1038/Nature10251 |
0.391 |
|
| 2011 |
Kappos L, Bates D, Edan G, Eraksoy M, Garcia-Merino A, Grigoriadis N, Hartung HP, Havrdová E, Hillert J, Hohlfeld R, Kremenchutzky M, Lyon-Caen O, Miller A, Pozzilli C, Ravnborg M, ... ... Hauser S, et al. Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring. The Lancet. Neurology. 10: 745-58. PMID 21777829 DOI: 10.1016/S1474-4422(11)70149-1 |
0.325 |
|
| 2011 |
McElroy JP, Isobe N, Gourraud PA, Caillier SJ, Matsushita T, Kohriyama T, Miyamoto K, Nakatsuji Y, Miki T, Hauser SL, Oksenberg JR, Kira J. SNP-based analysis of the HLA locus in Japanese multiple sclerosis patients. Genes and Immunity. 12: 523-30. PMID 21654846 DOI: 10.1038/Gene.2011.25 |
0.341 |
|
| 2011 |
Zuvich RL, Bush WS, McCauley JL, Beecham AH, De Jager PL, Ivinson AJ, Compston A, Hafler DA, Hauser SL, Sawcer SJ, Pericak-Vance MA, Barcellos LF, Mortlock DP, Haines JL. Interrogating the complex role of chromosome 16p13.13 in multiple sclerosis susceptibility: independent genetic signals in the CIITA-CLEC16A-SOCS1 gene complex. Human Molecular Genetics. 20: 3517-24. PMID 21653641 DOI: 10.1093/Hmg/Ddr250 |
0.408 |
|
| 2011 |
Gelfand JM, Cree BA, McElroy J, Oksenberg J, Green R, Mowry EM, Miller JW, Hauser SL, Green AJ. Vitamin D in African Americans with multiple sclerosis. Neurology. 76: 1824-30. PMID 21606454 DOI: 10.1212/Wnl.0B013E31821Cccf5 |
0.334 |
|
| 2011 |
Roosendaal SD, Bendfeldt K, Vrenken H, Polman CH, Borgwardt S, Radue EW, Kappos L, Pelletier D, Hauser SL, Matthews PM, Barkhof F, Geurts JJ. Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 1098-106. PMID 21586487 DOI: 10.1177/1352458511404916 |
0.331 |
|
| 2011 |
Bush WS, McCauley JL, DeJager PL, Dudek SM, Hafler DA, Gibson RA, Matthews PM, Kappos L, Naegelin Y, Polman CH, Hauser SL, Oksenberg J, Haines JL, Ritchie MD. A knowledge-driven interaction analysis reveals potential neurodegenerative mechanism of multiple sclerosis susceptibility. Genes and Immunity. 12: 335-40. PMID 21346779 DOI: 10.1038/Gene.2011.3 |
0.328 |
|
| 2011 |
Gourraud PA, McElroy JP, Caillier SJ, Johnson BA, Santaniello A, Hauser SL, Oksenberg JR. Aggregation of multiple sclerosis genetic risk variants in multiple and single case families. Annals of Neurology. 69: 65-74. PMID 21280076 DOI: 10.1002/Ana.22323 |
0.413 |
|
| 2011 |
Wang JH, Pappas D, De Jager PL, Pelletier D, de Bakker PI, Kappos L, Polman CH, Chibnik LB, Hafler DA, Matthews PM, Hauser SL, Baranzini SE, Oksenberg JR. Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data. Genome Medicine. 3: 3. PMID 21244703 DOI: 10.1186/Gm217 |
0.364 |
|
| 2010 |
Baranzini SE, Srinivasan R, Khankhanian P, Okuda DT, Nelson SJ, Matthews PM, Hauser SL, Oksenberg JR, Pelletier D. Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis. Brain : a Journal of Neurology. 133: 2603-11. PMID 20802204 DOI: 10.1093/Brain/Awq192 |
0.32 |
|
| 2010 |
Briggs FB, Bartlett SE, Goldstein BA, Wang J, McCauley JL, Zuvich RL, De Jager PL, Rioux JD, Ivinson AJ, Compston A, Hafler DA, Hauser SL, Oksenberg JR, Sawcer SJ, Pericak-Vance MA, et al. Evidence for CRHR1 in multiple sclerosis using supervised machine learning and meta-analysis in 12,566 individuals. Human Molecular Genetics. 19: 4286-95. PMID 20699326 DOI: 10.1093/Hmg/Ddq328 |
0.423 |
|
| 2010 |
Cree BA, Rioux JD, McCauley JL, Gourraud PA, Goyette P, McElroy J, De Jager P, Santaniello A, Vyse TJ, Gregersen PK, Mirel D, Hafler DA, Haines JL, Pericak-Vance MA, Compston A, ... ... Hauser SL, et al. A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01. Plos One. 5: e11296. PMID 20593013 DOI: 10.1371/Journal.Pone.0011296 |
0.363 |
|
| 2010 |
Ban M, McCauley JL, Zuvich R, Baker A, Bergamaschi L, Cox M, Kemppinen A, D'Alfonso S, Guerini FR, Lechner-Scott J, Dudbridge F, Wason J, Robertson NP, De Jager PL, Hafler DA, ... ... Hauser SL, et al. A non-synonymous SNP within membrane metalloendopeptidase-like 1 (MMEL1) is associated with multiple sclerosis. Genes and Immunity. 11: 660-4. PMID 20574445 DOI: 10.1038/Gene.2010.36 |
0.355 |
|
| 2010 |
Briggs FB, Goldstein BA, McCauley JL, Zuvich RL, De Jager PL, Rioux JD, Ivinson AJ, Compston A, Hafler DA, Hauser SL, Oksenberg JR, Sawcer SJ, Pericak-Vance MA, Haines JL, Barcellos LF, et al. Variation within DNA repair pathway genes and risk of multiple sclerosis. American Journal of Epidemiology. 172: 217-24. PMID 20522537 DOI: 10.1093/Aje/Kwq086 |
0.392 |
|
| 2010 |
Booth DR, Heard RN, Stewart GJ, Cox M, Scott RJ, Lechner-Scott J, Goris A, Dobosi R, Dubois B, Saarela J, Leppä V, Peltonen L, Pirttila T, Cournu-Rebeix I, ... ... Hauser SL, et al. Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis. Nature Genetics. 42: 469-70; author reply. PMID 20502484 DOI: 10.1038/Ng0610-469 |
0.313 |
|
| 2010 |
McElroy JP, Cree BA, Caillier SJ, Gregersen PK, Herbert J, Khan OA, Freudenberg J, Lee A, Bridges SL, Hauser SL, Oksenberg JR, Gourraud PA. Refining the association of MHC with multiple sclerosis in African Americans. Human Molecular Genetics. 19: 3080-8. PMID 20466734 DOI: 10.1093/Hmg/Ddq197 |
0.409 |
|
| 2010 |
Bar-Or A, Fawaz L, Fan B, Darlington PJ, Rieger A, Ghorayeb C, Calabresi PA, Waubant E, Hauser SL, Zhang J, Smith CH. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS? Annals of Neurology. 67: 452-61. PMID 20437580 DOI: 10.1002/Ana.21939 |
0.395 |
|
| 2010 |
Baranzini SE, Mudge J, van Velkinburgh JC, Khankhanian P, Khrebtukova I, Miller NA, Zhang L, Farmer AD, Bell CJ, Kim RW, May GD, Woodward JE, Caillier SJ, McElroy JP, Gomez R, ... ... Hauser SL, et al. Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis. Nature. 464: 1351-6. PMID 20428171 DOI: 10.1038/Nature08990 |
0.38 |
|
| 2010 |
Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R. Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain : a Journal of Neurology. 133: 1591-601. PMID 20410146 DOI: 10.1093/Brain/Awq080 |
0.342 |
|
| 2010 |
Bronson PG, Caillier S, Ramsay PP, McCauley JL, Zuvich RL, De Jager PL, Rioux JD, Ivinson AJ, Compston A, Hafler DA, Sawcer SJ, Pericak-Vance MA, Haines JL, Hauser SL, et al. CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis. Human Molecular Genetics. 19: 2331-40. PMID 20211854 DOI: 10.1093/Hmg/Ddq101 |
0.368 |
|
| 2010 |
Jakkula E, Leppä V, Sulonen AM, Varilo T, Kallio S, Kemppinen A, Purcell S, Koivisto K, Tienari P, Sumelahti ML, Elovaara I, Pirttilä T, Reunanen M, Aromaa A, Oturai AB, ... ... Hauser SL, et al. Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. American Journal of Human Genetics. 86: 285-91. PMID 20159113 DOI: 10.1016/J.Ajhg.2010.01.017 |
0.401 |
|
| 2010 |
Zuvich RL, McCauley JL, Oksenberg JR, Sawcer SJ, De Jager PL, Aubin C, Cross AH, Piccio L, Aggarwal NT, Evans D, Hafler DA, Compston A, Hauser SL, Pericak-Vance MA, et al. Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility. Human Genetics. 127: 525-35. PMID 20112030 DOI: 10.1007/S00439-010-0789-4 |
0.389 |
|
| 2010 |
Johnson BA, Wang J, Taylor EM, Caillier SJ, Herbert J, Khan OA, Cross AH, De Jager PL, Gourraud PA, Cree BC, Hauser SL, Oksenberg JR. Multiple sclerosis susceptibility alleles in African Americans. Genes and Immunity. 11: 343-50. PMID 19865102 DOI: 10.1038/Gene.2009.81 |
0.416 |
|
| 2009 |
Hawker K, O'Connor P, Freedman MS, Calabresi PA, Antel J, Simon J, Hauser S, Waubant E, Vollmer T, Panitch H, Zhang J, Chin P, Smith CH. Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. Annals of Neurology. 66: 460-71. PMID 19847908 DOI: 10.1002/Ana.21867 |
0.346 |
|
| 2009 |
Rioux JD, Goyette P, Vyse TJ, Hammarström L, Fernando MM, Green T, De Jager PL, Foisy S, Wang J, de Bakker PI, Leslie S, McVean G, Padyukov L, Alfredsson L, ... ... Hauser SL, et al. Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases. Proceedings of the National Academy of Sciences of the United States of America. 106: 18680-5. PMID 19846760 DOI: 10.1073/Pnas.0909307106 |
0.337 |
|
| 2009 |
McCauley JL, Zuvich RL, Bradford Y, Kenealy SJ, Schnetz-Boutaud N, Gregory SG, Hauser SL, Oksenberg JR, Mortlock DP, Pericak-Vance MA, Haines JL. Follow-up examination of linkage and association to chromosome 1q43 in multiple sclerosis. Genes and Immunity. 10: 624-30. PMID 19626040 DOI: 10.1038/Gene.2009.53 |
0.356 |
|
| 2009 |
De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, Aggarwal NT, Piccio L, Raychaudhuri S, Tran D, Aubin C, Briskin R, Romano S, Baranzini SE, McCauley JL, ... ... Hauser SL, et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nature Genetics. 41: 776-82. PMID 19525953 DOI: 10.1038/Ng.401 |
0.386 |
|
| 2009 |
Mowry EM, Beheshtian A, Waubant E, Goodin DS, Cree BA, Qualley P, Lincoln R, George MF, Gomez R, Hauser SL, Okuda DT, Pelletier D. Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures. Neurology. 72: 1760-5. PMID 19451531 DOI: 10.1212/Wnl.0B013E3181A609F8 |
0.334 |
|
| 2009 |
Ban M, Goris A, Lorentzen AR, Baker A, Mihalova T, Ingram G, Booth DR, Heard RN, Stewart GJ, Bogaert E, Dubois B, Harbo HF, Celius EG, Spurkland A, Strange R, ... ... Hauser SL, et al. Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor. European Journal of Human Genetics : Ejhg. 17: 1309-13. PMID 19293837 DOI: 10.1038/Ejhg.2009.41 |
0.342 |
|
| 2009 |
Baranzini SE, Galwey NW, Wang J, Khankhanian P, Lindberg R, Pelletier D, Wu W, Uitdehaag BM, Kappos L, Polman CH, Matthews PM, Hauser SL, Gibson RA, Oksenberg JR, et al. Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Human Molecular Genetics. 18: 2078-90. PMID 19286671 DOI: 10.1093/Hmg/Ddp120 |
0.392 |
|
| 2009 |
De Jager PL, Baecher-Allan C, Maier LM, Arthur AT, Ottoboni L, Barcellos L, McCauley JL, Sawcer S, Goris A, Saarela J, Yelensky R, Price A, Leppa V, Patterson N, de Bakker PI, ... ... Hauser SL, et al. The role of the CD58 locus in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. 106: 5264-9. PMID 19237575 DOI: 10.1073/Pnas.0813310106 |
0.354 |
|
| 2009 |
Cree BA, Reich DE, Khan O, De Jager PL, Nakashima I, Takahashi T, Bar-Or A, Tong C, Hauser SL, Oksenberg JR. Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA. Archives of Neurology. 66: 226-33. PMID 19204159 DOI: 10.1001/Archneurol.2008.541 |
0.399 |
|
| 2009 |
Maier LM, Lowe CE, Cooper J, Downes K, Anderson DE, Severson C, Clark PM, Healy B, Walker N, Aubin C, Oksenberg JR, Hauser SL, Compston A, Sawcer S, et al. IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production. Plos Genetics. 5: e1000322. PMID 19119414 DOI: 10.1371/Journal.Pgen.1000322 |
0.416 |
|
| 2009 |
Okuda DT, Mowry EM, Beheshtian A, Waubant E, Baranzini SE, Goodin DS, Hauser SL, Pelletier D. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology. 72: 800-5. PMID 19073949 DOI: 10.1212/01.Wnl.0000335764.14513.1A |
0.366 |
|
| 2009 |
Okuda DT, Srinivasan R, Oksenberg JR, Goodin DS, Baranzini SE, Beheshtian A, Waubant E, Zamvil SS, Leppert D, Qualley P, Lincoln R, Gomez R, Caillier S, George M, Wang J, ... ... Hauser SL, et al. Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain : a Journal of Neurology. 132: 250-9. PMID 19022862 DOI: 10.1093/Brain/Awn301 |
0.411 |
|
| 2009 |
Baranzini SE, Wang J, Gibson RA, Galwey N, Naegelin Y, Barkhof F, Radue EW, Lindberg RL, Uitdehaag BM, Johnson MR, Angelakopoulou A, Hall L, Richardson JC, Prinjha RK, Gass A, ... ... Hauser SL, et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Human Molecular Genetics. 18: 767-78. PMID 19010793 DOI: 10.1093/Hmg/Ddn388 |
0.406 |
|
| 2008 |
Hauser SL. Multiple lessons for multiple sclerosis. The New England Journal of Medicine. 359: 1838-41. PMID 18946071 DOI: 10.1056/Nejme0806738 |
0.385 |
|
| 2008 |
Caillier SJ, Briggs F, Cree BA, Baranzini SE, Fernandez-Viña M, Ramsay PP, Khan O, Royal W, Hauser SL, Barcellos LF, Oksenberg JR. Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis. Journal of Immunology (Baltimore, Md. : 1950). 181: 5473-80. PMID 18832704 DOI: 10.4049/Jimmunol.181.8.5473 |
0.377 |
|
| 2008 |
Corvol JC, Pelletier D, Henry RG, Caillier SJ, Wang J, Pappas D, Casazza S, Okuda DT, Hauser SL, Oksenberg JR, Baranzini SE. Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event. Proceedings of the National Academy of Sciences of the United States of America. 105: 11839-44. PMID 18689680 DOI: 10.1073/Pnas.0805065105 |
0.384 |
|
| 2008 |
Barcellos LF, Ramsay PP, Caillier SJ, Sawcer S, Haines J, Schmidt S, Pericak-Vance M, Compston DA, Gabatto P, Hauser SL, Oksenberg JR. Genetic variation in nitric oxide synthase 2A (NOS2A) and risk for multiple sclerosis. Genes and Immunity. 9: 493-500. PMID 18580885 DOI: 10.1038/Gene.2008.41 |
0.43 |
|
| 2008 |
Oksenberg JR, Baranzini SE, Sawcer S, Hauser SL. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nature Reviews. Genetics. 9: 516-26. PMID 18542080 DOI: 10.1038/Nrg2395 |
0.43 |
|
| 2008 |
Hauser SL, Waubant E, Arnold DL, Vollmer T, Antel J, Fox RJ, Bar-Or A, Panzara M, Sarkar N, Agarwal S, Langer-Gould A, Smith CH. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. The New England Journal of Medicine. 358: 676-88. PMID 18272891 DOI: 10.1056/Nejmoa0706383 |
0.334 |
|
| 2008 |
De Jager P, Baecher-Allan C, Maier L, Sawcer S, Goris A, Saarela J, Barcellos L, Dubois B, Peltonen L, Palotie A, Weiner H, Booth D, Stewart G, Pericak-Vance M, Haines J, ... ... Hauser S, et al. OR.102. The CD58 Pathway is Implicated in MS Susceptibility Clinical Immunology. 127: S40-S41. DOI: 10.1016/J.Clim.2008.03.109 |
0.335 |
|
| 2007 |
Begovich AB, Chang M, Caillier SJ, Lew D, Catanese JJ, Wang J, Hauser SL, Oksenberg JR. The autoimmune disease-associated IL12B and IL23R polymorphisms in multiple sclerosis. Human Immunology. 68: 934-7. PMID 18082575 DOI: 10.1016/J.Humimm.2007.09.005 |
0.405 |
|
| 2007 |
McCauley JL, Kenealy SJ, Margulies EH, Schnetz-Boutaud N, Gregory SG, Hauser SL, Oksenberg JR, Pericak-Vance MA, Haines JL, Mortlock DP. SNPs in Multi-species Conserved Sequences (MCS) as useful markers in association studies: a practical approach. Bmc Genomics. 8: 266. PMID 17683615 DOI: 10.1186/1471-2164-8-266 |
0.332 |
|
| 2007 |
Gregory SG, Schmidt S, Seth P, Oksenberg JR, Hart J, Prokop A, Caillier SJ, Ban M, Goris A, Barcellos LF, Lincoln R, McCauley JL, Sawcer SJ, Compston DA, Dubois B, ... Hauser SL, et al. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nature Genetics. 39: 1083-91. PMID 17660817 DOI: 10.1038/Ng2103 |
0.345 |
|
| 2007 |
Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL, de Bakker PI, Gabriel SB, Mirel DB, Ivinson AJ, Pericak-Vance MA, Gregory SG, Rioux JD, McCauley JL, ... ... Hauser SL, et al. Risk alleles for multiple sclerosis identified by a genomewide study. The New England Journal of Medicine. 357: 851-62. PMID 17660530 DOI: 10.1056/Nejmoa073493 |
0.336 |
|
| 2007 |
Hensiek AE, Seaman SR, Barcellos LF, Oturai A, Eraksoi M, Cocco E, Vecsei L, Stewart G, Dubois B, Bellman-Strobl J, Leone M, Andersen O, Bencsik K, Booth D, Celius EG, ... ... Hauser SL, et al. Familial effects on the clinical course of multiple sclerosis. Neurology. 68: 376-83. PMID 17261686 DOI: 10.1212/01.Wnl.0000252822.53506.46 |
0.391 |
|
| 2007 |
Yeo TW, De Jager PL, Gregory SG, Barcellos LF, Walton A, Goris A, Fenoglio C, Ban M, Taylor CJ, Goodman RS, Walsh E, Wolfish CS, Horton R, Traherne J, Beck S, ... ... Hauser SL, et al. A second major histocompatibility complex susceptibility locus for multiple sclerosis. Annals of Neurology. 61: 228-36. PMID 17252545 DOI: 10.1002/Ana.21063 |
0.335 |
|
| 2007 |
Motsinger AA, Brassat D, Caillier SJ, Erlich HA, Walker K, Steiner LL, Barcellos LF, Pericak-Vance MA, Schmidt S, Gregory S, Hauser SL, Haines JL, Oksenberg JR, Ritchie MD. Complex gene-gene interactions in multiple sclerosis: a multifactorial approach reveals associations with inflammatory genes. Neurogenetics. 8: 11-20. PMID 17024427 DOI: 10.1007/S10048-006-0058-9 |
0.368 |
|
| 2007 |
Hauser SL, Barcellos LF, Pericak-Vance M, Haines JL, Oksenberg JR. Clustering of autoimmune disease in families at high risk for multiple sclerosis? - Authors' reply Lancet Neurology. 6: 207. DOI: 10.1016/S1474-4422(07)70044-3 |
0.311 |
|
| 2006 |
Barcellos LF, Kamdar BB, Ramsay PP, DeLoa C, Lincoln RR, Caillier S, Schmidt S, Haines JL, Pericak-Vance MA, Oksenberg JR, Hauser SL. Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study. The Lancet. Neurology. 5: 924-31. PMID 17052659 DOI: 10.1016/S1474-4422(06)70552-X |
0.378 |
|
| 2006 |
Hauser SL, Oksenberg JR. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron. 52: 61-76. PMID 17015227 DOI: 10.1016/J.Neuron.2006.09.011 |
0.405 |
|
| 2006 |
Barcellos LF, Sawcer S, Ramsay PP, Baranzini SE, Thomson G, Briggs F, Cree BC, Begovich AB, Villoslada P, Montalban X, Uccelli A, Savettieri G, Lincoln RR, DeLoa C, Haines JL, ... ... Hauser SL, et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Human Molecular Genetics. 15: 2813-24. PMID 16905561 DOI: 10.1093/Hmg/Ddl223 |
0.42 |
|
| 2006 |
Kantarci OH, Barcellos LF, Atkinson EJ, Ramsay PP, Lincoln R, Achenbach SJ, De Andrade M, Hauser SL, Weinshenker BG. Men transmit MS more often to their children vs women: the Carter effect. Neurology. 67: 305-10. PMID 16864824 DOI: 10.1212/01.Wnl.0000225070.13682.11 |
0.336 |
|
| 2006 |
Schmidt S, Pericak-Vance MA, Sawcer S, Barcellos LF, Hart J, Sims J, Prokop AM, van der Walt J, DeLoa C, Lincoln RR, Oksenberg JR, Compston A, Hauser SL, Haines JL, Gregory SG, et al. Allelic association of sequence variants in the herpes virus entry mediator-B gene (PVRL2) with the severity of multiple sclerosis. Genes and Immunity. 7: 384-92. PMID 16738668 DOI: 10.1038/Sj.Gene.6364311 |
0.417 |
|
| 2006 |
Burwick RM, Ramsay PP, Haines JL, Hauser SL, Oksenberg JR, Pericak-Vance MA, Schmidt S, Compston A, Sawcer S, Cittadella R, Savettieri G, Quattrone A, Polman CH, Uitdehaag BM, Zwemmer JN, et al. APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers. Neurology. 66: 1373-83. PMID 16682670 DOI: 10.1212/01.Wnl.0000210531.19498.3F |
0.421 |
|
| 2006 |
Brassat D, Motsinger AA, Caillier SJ, Erlich HA, Walker K, Steiner LL, Cree BA, Barcellos LF, Pericak-Vance MA, Schmidt S, Gregory S, Hauser SL, Haines JL, Oksenberg JR, Ritchie MD. Multifactor dimensionality reduction reveals gene-gene interactions associated with multiple sclerosis susceptibility in African Americans. Genes and Immunity. 7: 310-5. PMID 16625214 DOI: 10.1038/Sj.Gene.6364299 |
0.404 |
|
| 2006 |
Hauser SL. Multiple sclerosis: tip of the iceberg? Annals of Neurology. 59: 11A-12A. PMID 16566010 DOI: 10.1002/Ana.20846 |
0.396 |
|
| 2006 |
von Büdingen HC, Menge T, Hauser SL, Genain CP. Restrictive and diversifying elements of the anti-myelin/oligodendrocyte glycoprotein antibody response in primate experimental allergic encephalomyelitis. Immunogenetics. 58: 122-8. PMID 16528499 DOI: 10.1007/S00251-006-0100-Y |
0.357 |
|
| 2006 |
Traherne JA, Barcellos LF, Sawcer SJ, Compston A, Ramsay PP, Hauser SL, Oksenberg JR, Trowsdale J. Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15. Human Molecular Genetics. 15: 155-61. PMID 16321988 DOI: 10.1093/Hmg/Ddi436 |
0.424 |
|
| 2005 |
Frohman EM, Stüve O, Havrdova E, Corboy J, Achiron A, Zivadinov R, Sorensen PS, Phillips JT, Weinshenker B, Hawker K, Hartung HP, Steinman L, Zamvil S, Cree BA, Hauser S, et al. Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations. Archives of Neurology. 62: 1519-30. PMID 16216934 DOI: 10.1001/Archneur.62.10.1519 |
0.339 |
|
| 2005 |
Reich D, Patterson N, De Jager PL, McDonald GJ, Waliszewska A, Tandon A, Lincoln RR, DeLoa C, Fruhan SA, Cabre P, Bera O, Semana G, Kelly MA, Francis DA, Ardlie K, ... ... Hauser SL, et al. A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility. Nature Genetics. 37: 1113-8. PMID 16186815 DOI: 10.1038/Ng1646 |
0.361 |
|
| 2005 |
Frohman EM, Filippi M, Stuve O, Waxman SG, Corboy J, Phillips JT, Lucchinetti C, Wilken J, Karandikar N, Hemmer B, Monson N, De Keyser J, Hartung H, Steinman L, Oksenberg JR, ... ... Hauser S, et al. Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions. Archives of Neurology. 62: 1345-56. PMID 16157741 DOI: 10.1001/Archneur.62.9.1345 |
0.428 |
|
| 2005 |
Fernald GH, Yeh RF, Hauser SL, Oksenberg JR, Baranzini SE. Mapping gene activity in complex disorders: Integration of expression and genomic scans for multiple sclerosis. Journal of Neuroimmunology. 167: 157-69. PMID 16129498 DOI: 10.1016/J.Jneuroim.2005.06.032 |
0.343 |
|
| 2005 |
Menge T, Lalive PH, von Büdingen HC, Cree B, Hauser SL, Genain CP. Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis. The Journal of Allergy and Clinical Immunology. 116: 453-9. PMID 16083805 DOI: 10.1016/J.Jaci.2005.03.023 |
0.382 |
|
| 2005 |
Hauser SL. An update on multiple sclerosis. Journal of the Neurological Sciences. 228: 193-4. PMID 15694203 DOI: 10.1016/J.Jns.2004.10.007 |
0.459 |
|
| 2005 |
Brassat D, Salemi G, Barcellos LF, McNeill G, Proia P, Hauser SL, Oksenberg JR, Savettieri G. The HLA locus and multiple sclerosis in Sicily. Neurology. 64: 361-3. PMID 15668443 DOI: 10.1212/01.Wnl.0000149765.71212.0A |
0.355 |
|
| 2005 |
Oksenberg JR, Hauser SL. Genetics of multiple sclerosis. Neurologic Clinics. 23: 61-75, vi. PMID 15661088 DOI: 10.1016/J.Ncl.2004.09.006 |
0.4 |
|
| 2005 |
Begovich AB, Caillier SJ, Alexander HC, Penko JM, Hauser SL, Barcellos LF, Oksenberg JR. The R620W polymorphism of the protein tyrosine phosphatase PTPN22 is not associated with multiple sclerosis. American Journal of Human Genetics. 76: 184-7. PMID 15580548 DOI: 10.1086/427244 |
0.395 |
|
| 2004 |
Cree BA, Khan O, Bourdette D, Goodin DS, Cohen JA, Marrie RA, Glidden D, Weinstock-Guttman B, Reich D, Patterson N, Haines JL, Pericak-Vance M, DeLoa C, Oksenberg JR, Hauser SL. Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology. 63: 2039-45. PMID 15596747 DOI: 10.1212/01.Wnl.0000145762.60562.5D |
0.345 |
|
| 2004 |
Kenealy SJ, Babron MC, Bradford Y, Schnetz-Boutaud N, Haines JL, Rimmler JB, Schmidt S, Pericak-Vance MA, Barcellos LF, Lincoln RR, Oksenberg JR, Hauser SL, Clanet M, Brassat D, Edan G, et al. A second-generation genomic screen for multiple sclerosis. American Journal of Human Genetics. 75: 1070-8. PMID 15494893 DOI: 10.1086/426459 |
0.336 |
|
| 2004 |
von Büdingen HC, Hauser SL, Ouallet JC, Tanuma N, Menge T, Genain CP. Frontline: Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination. European Journal of Immunology. 34: 2072-83. PMID 15259004 DOI: 10.1002/Eji.200425050 |
0.36 |
|
| 2004 |
Barcellos LF, Begovich AB, Reynolds RL, Caillier SJ, Brassat D, Schmidt S, Grams SE, Walker K, Steiner LL, Cree BA, Stillman A, Lincoln RR, Pericak-Vance MA, Haines JL, Erlich HA, ... Hauser SL, et al. Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis. Annals of Neurology. 55: 793-800. PMID 15174013 DOI: 10.1002/Ana.20092 |
0.405 |
|
| 2004 |
Mirel DB, Barcellos LF, Wang J, Hauser SL, Oksenberg JR, Erlich HA. Analysis of IL4R haplotypes in predisposition to multiple sclerosis. Genes and Immunity. 5: 138-41. PMID 14712310 DOI: 10.1038/Sj.Gene.6364048 |
0.433 |
|
| 2004 |
Oksenberg JR, Barcellos LF, Cree BA, Baranzini SE, Bugawan TL, Khan O, Lincoln RR, Swerdlin A, Mignot E, Lin L, Goodin D, Erlich HA, Schmidt S, Thomson G, Reich DE, ... ... Hauser SL, et al. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. American Journal of Human Genetics. 74: 160-7. PMID 14669136 DOI: 10.1086/380997 |
0.405 |
|
| 2004 |
Pericak-Vance MA, Rimmler JB, Haines JL, Garcia ME, Oksenberg JR, Barcellos LF, Lincoln R, Hauser SL, Cournu-Rebeix I, Azoulay-Cayla A, Lyon-Caen O, Fontaine B, Duhamel E, Coppin H, Brassat D, et al. Investigation of seven proposed regions of linkage in multiple sclerosis: an American and French collaborative study. Neurogenetics. 5: 45-8. PMID 14595552 DOI: 10.1007/S10048-003-0163-Y |
0.354 |
|
| 2003 |
Rudick RA, Cookfair DL, Griffin J, Hauser S, Piantadosi S. Interferons in relapsing remitting multiple sclerosis. Lancet (London, England). 361: 1824; author reply 1. PMID 12781561 DOI: 10.1016/S0140-6736(03)13421-6 |
0.412 |
|
| 2003 |
Caillier S, Barcellos LF, Baranzini SE, Swerdlin A, Lincoln RR, Steinman L, Martin E, Haines JL, Pericak-Vance M, Hauser SL, Oksenberg JR. Osteopontin polymorphisms and disease course in multiple sclerosis. Genes and Immunity. 4: 312-5. PMID 12761568 DOI: 10.1038/Sj.Gene.6363952 |
0.411 |
|
| 2003 |
Sriram U, Barcellos LF, Villoslada P, Rio J, Baranzini SE, Caillier S, Stillman A, Hauser SL, Montalban X, Oksenberg JR. Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosis. Genes and Immunity. 4: 147-52. PMID 12618863 DOI: 10.1038/Sj.Gene.6363946 |
0.408 |
|
| 2003 |
Barcellos LF, Oksenberg JR, Begovich AB, Martin ER, Schmidt S, Vittinghoff E, Goodin DS, Pelletier D, Lincoln RR, Bucher P, Swerdlin A, Pericak-Vance MA, Haines JL, Hauser SL. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. American Journal of Human Genetics. 72: 710-6. PMID 12557126 DOI: 10.1086/367781 |
0.43 |
|
| 2002 |
Stüve O, Cree BC, von Büdingen HC, Yousef S, Bowen JD, Genain CP, Hauser SL, Steinman L, Zamvil SS. Approved and future pharmacotherapy for multiple sclerosis. The Neurologist. 8: 290-301. PMID 12803676 DOI: 10.1097/00127893-200209000-00002 |
0.402 |
|
| 2002 |
Baranzini SE, Hauser SL. Large-scale gene-expression studies and the challenge of multiple sclerosis. Genome Biology. 3: reviews1027. PMID 12372148 DOI: 10.1186/Gb-2002-3-10-Reviews1027 |
0.36 |
|
| 2002 |
Villoslada P, Barcellos LF, Rio J, Begovich AB, Tintore M, Sastre-Garriga J, Baranzini SE, Casquero P, Hauser SL, Montalban X, Oksenberg JR. The HLA locus and multiple sclerosis in Spain. Role in disease susceptibility, clinical course and response to interferon-beta. Journal of Neuroimmunology. 130: 194-201. PMID 12225902 DOI: 10.1016/S0165-5728(02)00215-1 |
0.39 |
|
| 2002 |
Haines JL, Bradford Y, Garcia ME, Reed AD, Neumeister E, Pericak-Vance MA, Rimmler JB, Menold MM, Martin ER, Oksenberg JR, Barcellos LF, Lincoln R, Hauser SL. Multiple susceptibility loci for multiple sclerosis. Human Molecular Genetics. 11: 2251-6. PMID 12217953 DOI: 10.1093/Hmg/11.19.2251 |
0.354 |
|
| 2002 |
von Büdingen HC, Hauser SL, Fuhrmann A, Nabavi CB, Lee JI, Genain CP. Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination. Proceedings of the National Academy of Sciences of the United States of America. 99: 8207-12. PMID 12060766 DOI: 10.1073/Pnas.122092499 |
0.319 |
|
| 2002 |
Koehler NK, Genain CP, Giesser B, Hauser SL. The human T cell response to myelin oligodendrocyte glycoprotein: a multiple sclerosis family-based study. Journal of Immunology (Baltimore, Md. : 1950). 168: 5920-7. PMID 12023398 DOI: 10.4049/Jimmunol.168.11.5920 |
0.366 |
|
| 2002 |
Schmidt S, Barcellos LF, DeSombre K, Rimmler JB, Lincoln RR, Bucher P, Saunders AM, Lai E, Martin ER, Vance JM, Oksenberg JR, Hauser SL, Pericak-Vance MA, Haines JL. Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis. American Journal of Human Genetics. 70: 708-17. PMID 11836653 DOI: 10.1086/339269 |
0.422 |
|
| 2002 |
Barcellos LF, Oksenberg JR, Green AJ, Bucher P, Rimmler JB, Schmidt S, Garcia ME, Lincoln RR, Pericak-Vance MA, Haines JL, Hauser SL. Genetic basis for clinical expression in multiple sclerosis. Brain : a Journal of Neurology. 125: 150-8. PMID 11834600 DOI: 10.1093/Brain/Awf009 |
0.37 |
|
| 2001 |
Genain CP, Hauser SL. Experimental allergic encephalomyelitis in the New World monkey Callithrix jacchus. Immunological Reviews. 183: 159-72. PMID 11782255 DOI: 10.1034/J.1600-065X.2001.1830113.X |
0.416 |
|
| 2001 |
Pericak-Vance MA, Rimmler JB, Martin ER, Haines JL, Garcia ME, Oksenberg JR, Barcellos LF, Lincoln R, Goodkin DE, Hauser SL. Linkage and association analysis of chromosome 19q13 in multiple sclerosis. Neurogenetics. 3: 195-201. PMID 11714099 DOI: 10.1007/S100480100119 |
0.417 |
|
| 2001 |
Villoslada P, Abel K, Heald N, Goertsches R, Hauser SL, Genain CP. Frequency, heterogeneity and encephalitogenicity of T cells specific for myelin oligodendrocyte glycoprotein in naive outbred primates. European Journal of Immunology. 31: 2942-50. PMID 11592070 DOI: 10.1002/1521-4141(2001010)31:10<2942::Aid-Immu2942>3.0.Co;2-M |
0.351 |
|
| 2001 |
Green AJ, Bollen AW, Berger MS, Oksenberg JR, Hauser SL. Multiple sclerosis and oligodendroglioma. Multiple Sclerosis (Houndmills, Basingstoke, England). 7: 269-73. PMID 11548988 DOI: 10.1177/135245850100700410 |
0.416 |
|
| 2001 |
Barcellos LF, Caillier S, Dragone L, Elder M, Vittinghoff E, Bucher P, Lincoln RR, Pericak-Vance M, Haines JL, Weiss A, Hauser SL, Oksenberg JR. PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patients. Nature Genetics. 29: 23-4. PMID 11528386 DOI: 10.1038/Ng722 |
0.397 |
|
| 2001 |
Mohr DC, Goodkin DE, Islar J, Hauser SL, Genain CP. Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis. Archives of Neurology. 58: 1081-6. PMID 11448297 DOI: 10.1001/Archneur.58.7.1081 |
0.303 |
|
| 2001 |
von Büdingen HC, Tanuma N, Villoslada P, Ouallet JC, Hauser SL, Genain CP. Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination. Journal of Clinical Immunology. 21: 155-70. PMID 11403222 DOI: 10.1023/A:1011031014433 |
0.334 |
|
| 2001 |
Green AJ, Barcellos LF, Rimmler JB, Garcia ME, Caillier S, Lincoln RR, Bucher P, Pericak-Vance MA, Haines JL, Hauser SL, Oksenberg JR. Sequence variation in the transforming growth factor-beta1 (TGFB1) gene and multiple sclerosis susceptibility. Journal of Neuroimmunology. 116: 116-24. PMID 11311337 DOI: 10.1016/S0165-5728(01)00283-1 |
0.391 |
|
| 2001 |
Uccelli A, Giunti D, Mancardi G, Caroli F, Fiorone M, Seri M, Hauser SL, Genain CP. Characterization of the response to myelin basic protein in a non human primate model for multiple sclerosis. European Journal of Immunology. 31: 474-9. PMID 11180112 DOI: 10.1002/1521-4141(200102)31:2<474::Aid-Immu474>3.0.Co;2-9 |
0.372 |
|
| 2001 |
Oksenberg JR, Baranzini SE, Barcellos LF, Hauser SL. Multiple sclerosis: genomic rewards. Journal of Neuroimmunology. 113: 171-84. PMID 11164900 DOI: 10.1016/S0165-5728(00)00444-6 |
0.43 |
|
| 2000 |
Hauser SL, Oksenberg JR, Lincoln R, Garovoy J, Beck RW, Cole SR, Moke PS, Kip KE, Gal RL, Long DT. Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS American Journal of Ophthalmology. 130: 690-1. PMID 11078868 DOI: 10.1016/S0002-9394(00)00761-3 |
0.333 |
|
| 2000 |
Villoslada P, Hauser SL, Bartke I, Unger J, Heald N, Rosenberg D, Cheung SW, Mobley WC, Fisher S, Genain CP. Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system. The Journal of Experimental Medicine. 191: 1799-806. PMID 10811872 DOI: 10.1084/Jem.191.10.1799 |
0.31 |
|
| 2000 |
Barcellos LF, Schito AM, Rimmler JB, Vittinghoff E, Shih A, Lincoln R, Callier S, Elkins MK, Goodkin DE, Haines JL, Pericak-Vance MA, Hauser SL, Oksenberg JR. CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group. Immunogenetics. 51: 281-8. PMID 10803840 DOI: 10.1007/S002510050621 |
0.437 |
|
| 2000 |
Hauser SL, Oksenberg JR, Lincoln R, Garovoy J, Beck RW, Cole SR, Moke PS, Kip KE, Gal RL, Long DT. Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study Group. Neurology. 54: 1859-61. PMID 10802800 DOI: 10.1212/Wnl.54.9.1859 |
0.365 |
|
| 1999 |
Oksenberg JR, Barcellos LF, Hauser SL. Genetic aspects of multiple sclerosis. Seminars in Neurology. 19: 281-8. PMID 12194384 DOI: 10.1055/S-2008-1040844 |
0.424 |
|
| 1999 |
Fontaine B, Cournu I, Arnaud I, Babron MC, Eichenbaum-Voline S, Oksenberg JR, Pericak-Vance MA, Haines JL, Semama G, Liblau R, Lyon-Caen O, Clerget-Darpoux F, Clanet M, Hauser SL. Chromosome 17q22-q24 and multiple sclerosis genetic susceptibility. American-French Multiple Sclerosis Genetic Group. Genes and Immunity. 1: 149-50. PMID 11196661 DOI: 10.1038/Sj.Gene.6363646 |
0.36 |
|
| 1999 |
Seboun E, Oksenberg JR, Rombos A, Usuku K, Goodkin DE, Lincoln RR, Wong M, Pham-Dinh D, Boesplug-Tanguy O, Carsique R, Fitoussi R, Gartioux C, Reyes C, Ribierre F, Faure S, ... ... Hauser SL, et al. Linkage analysis of candidate myelin genes in familial multiple sclerosis. Neurogenetics. 2: 155-62. PMID 10541588 DOI: 10.1007/S100480050076 |
0.395 |
|
| 1999 |
Diaz-Villoslada P, Shih A, Shao L, Genain CP, Hauser SL. Autoreactivity to myelin antigens: myelin/oligodendrocyte glycoprotein is a prevalent autoantigen. Journal of Neuroimmunology. 99: 36-43. PMID 10496175 DOI: 10.1016/S0165-5728(99)00099-5 |
0.41 |
|
| 1999 |
Raine CS, Cannella B, Hauser SL, Genain CP. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Annals of Neurology. 46: 144-60. PMID 10443879 DOI: 10.1002/1531-8249(199908)46:2<144::Aid-Ana3>3.0.Co;2-K |
0.359 |
|
| 1999 |
Genain CP, Cannella B, Hauser SL, Raine CS. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nature Medicine. 5: 170-5. PMID 9930864 DOI: 10.1038/5532 |
0.319 |
|
| 1998 |
Hauser SL. Multiple sclerosis: basic immunology. The Journal of Spinal Cord Medicine. 21: 106-8. PMID 9697083 DOI: 10.1080/10790268.1998.11719515 |
0.419 |
|
| 1998 |
Haines JL, Terwedow HA, Burgess K, Pericak-Vance MA, Rimmler JB, Martin ER, Oksenberg JR, Lincoln R, Zhang DY, Banatao DR, Gatto N, Goodkin DE, Hauser SL. Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group. Human Molecular Genetics. 7: 1229-34. PMID 9668163 DOI: 10.1093/Hmg/7.8.1229 |
0.394 |
|
| 1997 |
Genain CP, Gritz L, Joshi N, Panicali D, Davis RL, Whitaker JN, Letvin NL, Hauser SL. Inhibition of allergic encephalomyelitis in marmosets by vaccination with recombinant vaccinia virus encoding for myelin basic protein. Journal of Neuroimmunology. 79: 119-28. PMID 9394784 DOI: 10.1016/S0165-5728(97)00109-4 |
0.31 |
|
| 1997 |
Oksenberg JR, Hauser SL. New insights into the immunogenetics of multiple sclerosis. Current Opinion in Neurology. 10: 181-5. PMID 9229123 DOI: 10.1097/00019052-199706000-00003 |
0.347 |
|
| 1997 |
Genain CP, Hauser SL. Creation of a model for multiple sclerosis in Callithrix jacchus marmosets. Journal of Molecular Medicine (Berlin, Germany). 75: 187-97. PMID 9106075 DOI: 10.1007/S001090050103 |
0.44 |
|
| 1996 |
Genain CP, Hauser SL. Allergic Encephalomyelitis in Common Marmosets: Pathogenesis of a Multiple Sclerosis-like Lesion Methods (San Diego, Calif.). 10: 420-34. PMID 8954853 DOI: 10.1006/Meth.1996.0120 |
0.417 |
|
| 1996 |
Genain CP, Abel K, Belmar N, Villinger F, Rosenberg DP, Linington C, Raine CS, Hauser SL. Late complications of immune deviation therapy in a nonhuman primate. Science (New York, N.Y.). 274: 2054-7. PMID 8953031 DOI: 10.1126/Science.274.5295.2054 |
0.32 |
|
| 1996 |
Usuku K, Joshi N, Hatem CJ, Wong MA, Stein MC, Hauser SL. Biased expression of T cell receptor genes characterizes activated T cells in multiple sclerosis cerebrospinal fluid. Journal of Neuroscience Research. 45: 829-37. PMID 8892095 DOI: 10.1002/(Sici)1097-4547(19960915)45:6<829::Aid-Jnr20>3.0.Co;2-P |
0.306 |
|
| 1996 |
Garcia-Merino A, Alper CA, Usuku K, Marcus-Bagley D, Lincoln R, Awdeh Z, Yunis EJ, Eisenbarth GS, Brink SJ, Hauser SL. Tumor necrosis factor (TNF) microsatellite haplotypes in relation to extended haplotypes, susceptibility to diseases associated with the major histocompatibility complex and TNF secretion. Human Immunology. 50: 11-21. PMID 8872171 DOI: 10.1016/0198-8859(96)00064-X |
0.325 |
|
| 1996 |
Oksenberg JR, Seboun E, Hauser SL. Genetics of demyelinating diseases. Brain Pathology (Zurich, Switzerland). 6: 289-302. PMID 8864285 DOI: 10.1111/J.1750-3639.1996.Tb00856.X |
0.431 |
|
| 1996 |
Haines JL, Ter-Minassian M, Bazyk A, Gusella JF, Kim DJ, Terwedow H, Pericak-Vance MA, Rimmler JB, Haynes CS, Roses AD, Lee A, Shaner B, Menold M, Seboun E, Fitoussi RP, ... ... Hauser SL, et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nature Genetics. 13: 469-71. PMID 8696344 DOI: 10.1038/Ng0896-469 |
0.309 |
|
| 1996 |
Neilley LK, Goodin DS, Goodkin DE, Hauser SL. Side effect profile of interferon beta-1b in MS: results of an open label trial. Neurology. 46: 552-4. PMID 8614531 DOI: 10.1212/Wnl.46.2.552 |
0.333 |
|
| 1995 |
Genain CP, Nguyen MH, Letvin NL, Pearl R, Davis RL, Adelman M, Lees MB, Linington C, Hauser SL. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. The Journal of Clinical Investigation. 96: 2966-74. PMID 8675668 DOI: 10.1172/Jci118368 |
0.393 |
|
| 1995 |
Rozniecki JJ, Hauser SL, Stein M, Lincoln R, Theoharides TC. Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Annals of Neurology. 37: 63-6. PMID 7818259 DOI: 10.1002/Ana.410370112 |
0.426 |
|
| 1995 |
Massacesi L, Genain CP, Lee-Parritz D, Letvin NL, Canfield D, Hauser SL. Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis. Annals of Neurology. 37: 519-30. PMID 7717689 DOI: 10.1002/Ana.410370415 |
0.353 |
|
| 1995 |
Hauser SL. T-cell receptor genes. Germline polymorphisms and genetic susceptibility to demyelinating diseases. Annals of the New York Academy of Sciences. 756: 233-40. PMID 7645843 DOI: 10.1111/J.1749-6632.1995.Tb44521.X |
0.312 |
|
| 1995 |
Genain CP, Roberts T, Davis RL, Nguyen MH, Uccelli A, Faulds D, Li Y, Hedgpeth J, Hauser SL. Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor. Proceedings of the National Academy of Sciences of the United States of America. 92: 3601-5. PMID 7536938 DOI: 10.1073/Pnas.92.8.3601 |
0.333 |
|
| 1994 |
Genain CP, Lee-Parritz D, Nguyen MH, Massacesi L, Joshi N, Ferrante R, Hoffman K, Moseley M, Letvin NL, Hauser SL. In healthy primates, circulating autoreactive T cells mediate autoimmune disease. The Journal of Clinical Investigation. 94: 1339-45. PMID 7521889 DOI: 10.1172/Jci117454 |
0.33 |
|
| 1994 |
Hauser SL. Prevention strategies for multiple sclerosis. Annals of Neurology. 36: S157-62. PMID 7517124 DOI: 10.1002/Ana.410360738 |
0.414 |
|
| 1994 |
Hauser SL. Treatment of Multiple Sclerosis: Trial Design, Results, and Future Perspectives Neurology. 44: 200-200. DOI: 10.1212/Wnl.44.1.200-A |
0.307 |
|
| 1993 |
Yu JS, Pandey JP, Massacesi L, Lincoln R, Usuku K, Seboun E, Hauser SL. Segregation of immunoglobulin heavy chain constant region genes in multiple sclerosis sibling pairs. Journal of Neuroimmunology. 42: 113-6. PMID 8423203 DOI: 10.1016/0165-5728(93)90218-N |
0.318 |
|
| 1993 |
Weiner HL, Mackin GA, Orav EJ, Hafler DA, Dawson DM, LaPierre Y, Herndon R, Lehrich JR, Hauser SL, Turel A. Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group. Neurology. 43: 910-8. PMID 8388090 DOI: 10.1212/Wnl.43.5.910 |
0.339 |
|
| 1993 |
Joshi N, Usuku K, Hauser SL. The T-cell response to myelin basic protein in familial multiple sclerosis: diversity of fine specificity, restricting elements, and T-cell receptor usage. Annals of Neurology. 34: 385-93. PMID 7689820 DOI: 10.1002/Ana.410340313 |
0.422 |
|
| 1992 |
Hauser SL, Doolittle TH, Lopez-Bresnahan M, Shahani B, Schoenfeld D, Shih VE, Growdon J, Lehrich JR. An antispasticity effect of threonine in multiple sclerosis. Archives of Neurology. 49: 923-6. PMID 1520082 DOI: 10.1001/Archneur.1992.00530330045014 |
0.317 |
|
| 1992 |
Massacesi L, Joshi N, Lee-Parritz D, Rombos A, Letvin NL, Hauser SL. Experimental allergic encephalomyelitis in cynomolgus monkeys. Quantitation of T cell responses in peripheral blood. The Journal of Clinical Investigation. 90: 399-404. PMID 1379611 DOI: 10.1172/Jci115874 |
0.312 |
|
| 1991 |
Yu JS, Hayashi T, Seboun E, Sklar RM, Doolittle TH, Hauser SL. Fos RNA accumulation in multiple sclerosis white matter tissue. Journal of the Neurological Sciences. 103: 209-15. PMID 1715387 DOI: 10.1016/0022-510X(91)90166-5 |
0.352 |
|
| 1990 |
Hauser SL, Doolittle TH, Lincoln R, Brown RH, Dinarello CA. Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology. 40: 1735-9. PMID 2234430 DOI: 10.1212/Wnl.40.11.1735 |
0.342 |
|
| 1990 |
Doolittle TH, Myers RH, Lehrich JR, Birnbaum G, Sheremata W, Franklin GM, Nelson LM, Hauser SL. Multiple sclerosis sibling pairs: clustered onset and familial predisposition. Neurology. 40: 1546-52. PMID 2215946 DOI: 10.1212/Wnl.40.10.1546 |
0.357 |
|
| 1989 |
Hauser SL, Fleischnick E, Weiner HL, Marcus D, Awdeh Z, Yunis EJ, Alper CA. Extended major histocompatibility complex haplotypes in patients with multiple sclerosis. Neurology. 39: 275-7. PMID 2783768 DOI: 10.1212/Wnl.39.2.275 |
0.417 |
|
| 1989 |
Seboun E, Robinson MA, Doolittle TH, Ciulla TA, Kindt TJ, Hauser SL. A susceptibility locus for multiple sclerosis is linked to the T cell receptor beta chain complex. Cell. 57: 1095-100. PMID 2567636 DOI: 10.1016/0092-8674(89)90046-9 |
0.406 |
|
| 1989 |
Kostyk SK, Kowall NW, Hauser SL. Substance P immunoreactive astrocytes are present in multiple sclerosis plaques. Brain Research. 504: 284-8. PMID 2480834 DOI: 10.1016/0006-8993(89)91369-3 |
0.385 |
|
| 1988 |
Hayashi T, Morimoto C, Burks JS, Kerr C, Hauser SL. Dual-label immunocytochemistry of the active multiple sclerosis lesion: major histocompatibility complex and activation antigens. Annals of Neurology. 24: 523-31. PMID 3266456 DOI: 10.1002/Ana.410240408 |
0.382 |
|
| 1988 |
Hayashi T, Burks JS, Hauser SL. Expression and cellular localization of major histocompatibility complex antigens in active multiple sclerosis lesions. Annals of the New York Academy of Sciences. 540: 301-5. PMID 3061338 DOI: 10.1111/J.1749-6632.1988.Tb27081.X |
0.307 |
|
| 1988 |
Ciulla TA, Robinson MA, Seboun E, Doolittle TH, Hayashi T, Kindt TJ, Hauser SL. Molecular genotypes of the T-cell receptor beta chain in families with multiple sclerosis. Annals of the New York Academy of Sciences. 540: 271-6. PMID 2905120 DOI: 10.1111/J.1749-6632.1988.Tb27074.X |
0.3 |
|
| 1988 |
Robinson MA, Ciulla T, Seboun E, Doolittle T, Kindt TJ, Hauser S. The inheritance of T cell receptor genes in multiplex families with multiple sclerosis Human Immunology. 23: 139-140. DOI: 10.1016/0198-8859(88)90245-5 |
0.323 |
|
| 1987 |
Hayashi T, Morimoto C, Burks JS, Kerr C, Ringler DJ, Hauser SL. Double-label immunochemical analysis of T-cell activation markers and MHC expression in active multiple sclerosis lesions Journal of Neuroimmunology. 16: 74. DOI: 10.1016/0165-5728(87)90241-4 |
0.324 |
|
| 1987 |
Ciulla TA, Robinson MA, Doolittle T, Kindt TJ, Hauser SL. Molecular genotyping of the T-cell receptor beta chain in families of multiple sclerosis patients Journal of Neuroimmunology. 16: 34-35. DOI: 10.1016/0165-5728(87)90179-2 |
0.309 |
|
| 1986 |
Brown RH, Hauser SL, Harrington H, Weiner HL. Failure of Immunosuppression With a Ten- to 14-Day Course of High-Dose Intravenous Cyclophosphamide to Alter the Progression of Amyotrophic Lateral Sclerosis Jama Neurology. 43: 383-384. PMID 3954622 DOI: 10.1001/Archneur.1986.00520040063021 |
0.32 |
|
| 1986 |
Lyon-Caen O, Jouvent R, Hauser S, Chaunu MP, Benoit N, Widlöcher D, Lhermitte F. Cognitive function in recent-onset demyelinating diseases. Archives of Neurology. 43: 1138-41. PMID 3778246 DOI: 10.1001/Archneur.1986.00520110034010 |
0.313 |
|
| 1986 |
Hauser SL, Bhan AK, Gilles F, Kemp M, Kerr C, Weiner HL. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions Annals of Neurology. 19: 578-587. PMID 3524414 DOI: 10.1002/Ana.410190610 |
0.302 |
|
| 1986 |
Hauser SL, Aubert C, Burks JS, Kerr C, Lyon-Caen O, Brahic M. Analysis of human T-lymphotropic virus sequences in multiple sclerosis tissue Nature. 322: 176-177. PMID 3014351 DOI: 10.1038/322176A0 |
0.418 |
|
| 1985 |
Hauser SL, Ault KA, Johnson D, Hoban C, Weiner HL. Increased IgG secretion by unstimulated mononuclear cells in active multiple sclerosis and functional assessment of the T8 subset. Clinical Immunology and Immunopathology. 37: 312-323. PMID 2932271 DOI: 10.1016/0090-1229(85)90101-1 |
0.402 |
|
| 1984 |
Hauser SL, Fosburg M, Kevy SV, Weiner HL. Lymphocytapheresis in chronic progressive multiple sclerosis Immunologic and clinical effects Neurology. 34: 922-922. PMID 6539868 DOI: 10.1212/Wnl.34.7.922 |
0.342 |
|
| 1984 |
Weiner HL, Hafler DA, Fallis RJ, Johnson D, Ault KA, Hauser SL. Altered blood T-cell subsets in patients with multiple sclerosis Journal of Neuroimmunology. 6: 115-121. PMID 6373819 DOI: 10.1016/0165-5728(84)90032-8 |
0.369 |
|
| 1984 |
Weiner HL, Hafler DA, Fallis RJ, Johnson D, Ault KA, Hauser SL. T cell subsets in patients with multiple sclerosis. An overview. Annals of the New York Academy of Sciences. 436: 281-290. PMID 6152384 DOI: 10.1111/J.1749-6632.1984.Tb14800.X |
0.36 |
|
| 1984 |
Weiner HL, Hauser SL, Hafler DA, Fallis RJ, Lehrich JR, Dawson DM. The use of cyclophosphamide in the treatment of multiple sclerosis. Annals of the New York Academy of Sciences. 436: 373-381. PMID 6099707 DOI: 10.1111/J.1749-6632.1984.Tb14808.X |
0.336 |
|
| 1983 |
Hauser SL, Dawson DM, Lehrich JR, Beal MF, Kevy SV, Weiner HL. Immunosuppression and plasmapheresis in chronic progressive multiple sclerosis. Design of a clinical trial. Archives of Neurology. 40: 687-90. PMID 6354151 DOI: 10.1001/Archneur.1983.04050100027009 |
0.385 |
|
| 1983 |
Hauser SL, Reinherz EL, Hoban CJ, Schlossman SF, Weiner HL. CSF cells in multiple sclerosis: Monoclonal antibody analysis and relationship to peripheral blood T‐cell subsets Neurology. 33: 575-575. PMID 6341872 DOI: 10.1212/Wnl.33.5.575 |
0.325 |
|
| 1983 |
Weiner HL, Hauser SL. Immunoregulation in multiple sclerosis. Progress in Brain Research. 59: 339-343. PMID 6229809 DOI: 10.1016/S0079-6123(08)63879-0 |
0.385 |
|
| 1983 |
Hauser SL, Reinherz EL, Hoban CJ, Schlossman SF, Weiner HL. Immunoregulatory T‐cells and lymphocytotoxic antibodies in active multiple sclerosis: Weekly analysis over a six‐month period Annals of Neurology. 13: 418-425. PMID 6220668 DOI: 10.1002/Ana.410130408 |
0.374 |
|
| 1982 |
Hauser SL, Ropper AH, Perlo VP, Reinherz EL, Schlossman SF, Weiner HL. T-cell subsets in human autoimmune diseases. Neurology. 32: 1320-1. PMID 6982430 DOI: 10.1212/Wnl.32.11.1320-B |
0.524 |
|
| 1982 |
Hauser SL, Bresnan MJ, Reinherz EL, Weiner HL. Childhood multiple sclerosis: clinical features and demonstration of changes in T cell subsets with disease activity. Annals of Neurology. 11: 463-8. PMID 6213188 DOI: 10.1002/Ana.410110505 |
0.367 |
|
| 1982 |
Weiner HL, Hauser SL. Neuroimmunology I: Immunoregulation in neurological disease. Annals of Neurology. 11: 437-449. PMID 6179458 DOI: 10.1002/Ana.410110502 |
0.324 |
|
| 1982 |
Hauser SL, Weiner HL, Ault KA. Clonally restricted B cells in peripheral blood of multiple sclerosis patients: kappa/lambda staining patterns. Annals of Neurology. 11: 408-412. PMID 6179457 DOI: 10.1002/Ana.410110415 |
0.385 |
|
| 1980 |
Reinherz EL, Weiner HL, Hauser SL, Cohen JA, Distaso JA, Schlossman SF. Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies. The New England Journal of Medicine. 303: 125-129. PMID 6446039 DOI: 10.1056/Nejm198007173030303 |
0.39 |
|
| Show low-probability matches. |
